Literature DB >> 16246536

Drug permeability across a phospholipid vesicle based barrier: a novel approach for studying passive diffusion.

Gøril Eide Flaten1, Anand Babu Dhanikula, Kristina Luthman, Martin Brandl.   

Abstract

The aim of this study was to develop a novel predictive medium-throughput screening method for drug permeability, with use of a tight barrier of liposomes on a filter support. To our knowledge no one has succeeded in depositing membrane barriers without the use of an inert solvent such as hexadecane. The first part of the study involved development of a protocol for preparation of these barriers, which were made of liposomes from egg phosphatidylcholin in phosphate buffer pH 7.4 with 10 % (v/v) ethanol. The liposomes were deposited into the pores and onto the surface of a filter support (mixed cellulose ester) by use of centrifugation. Solvent evaporation and freeze-thaw cycling were then used to promote fusion of liposomes. A tight barrier could thus be obtained as shown with calcein permeability and electrical resistance. In the second part of the study the model was validated using 21 drug compounds, which cover a wide range of physicochemical properties and absorption (F(a)) in humans (13-100%). The drug permeation studies were carried out at room temperature with phosphate buffer (pH 7.4) in both acceptor and donor chambers. The apparent permeability coefficients obtained from the phospholipid vesicle based model correlated well with literature data on human absorption in vivo, which suggests that its performance is adequate and that the method is suitable for rapid screening of passive transport of new chemical entities. The results obtained from our model were compared with polar surface area (PSA) and experimental logD and with results obtained by established permeability screening methods such as immobilized liposome chromatography (ILC), the PAMPA models and the Caco-2 model. Our approach seems to model the in vivo absorption better than PSA, experimental logD, the ILC and PAMPA models, when similar conditions are used as in our assay, and equally well as the Caco-2 model and the Double Sink PAMPA (DS-PAMPA) model.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16246536     DOI: 10.1016/j.ejps.2005.08.007

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  14 in total

Review 1.  Application of method suitability for drug permeability classification.

Authors:  Donna A Volpe
Journal:  AAPS J       Date:  2010-09-02       Impact factor: 4.009

Review 2.  Coexistence of passive and carrier-mediated processes in drug transport.

Authors:  Kiyohiko Sugano; Manfred Kansy; Per Artursson; Alex Avdeef; Stefanie Bendels; Li Di; Gerhard F Ecker; Bernard Faller; Holger Fischer; Grégori Gerebtzoff; Hans Lennernaes; Frank Senner
Journal:  Nat Rev Drug Discov       Date:  2010-08       Impact factor: 84.694

Review 3.  Modeling kinetics of subcellular disposition of chemicals.

Authors:  Stefan Balaz
Journal:  Chem Rev       Date:  2009-05       Impact factor: 60.622

Review 4.  Human skin models: From healthy to disease-mimetic systems; characteristics and applications.

Authors:  Tânia Moniz; Sofia A Costa Lima; Salette Reis
Journal:  Br J Pharmacol       Date:  2020-08-19       Impact factor: 8.739

5.  In situ artificial membrane permeation assay under hydrodynamic control: permeability-pH profiles of warfarin and verapamil.

Authors:  Matej Velický; Dan F Bradley; Kin Y Tam; Robert A W Dryfe
Journal:  Pharm Res       Date:  2010-05-07       Impact factor: 4.200

Review 6.  Antimicrobial Peptide Mimics for Clinical Use: Does Size Matter?

Authors:  Johan Svenson; Natalia Molchanova; Christina I Schroeder
Journal:  Front Immunol       Date:  2022-05-26       Impact factor: 8.786

7.  Direct Optofluidic Measurement of the Lipid Permeability of Fluoroquinolones.

Authors:  Jehangir Cama; Michael Schaich; Kareem Al Nahas; Silvia Hernández-Ainsa; Stefano Pagliara; Ulrich F Keyser
Journal:  Sci Rep       Date:  2016-09-08       Impact factor: 4.379

Review 8.  Pharmacological Potential of the Endogenous Dipeptide Kyotorphin and Selected Derivatives.

Authors:  Juliana Perazzo; Miguel A R B Castanho; Sónia Sá Santos
Journal:  Front Pharmacol       Date:  2017-01-12       Impact factor: 5.810

9.  Effective mucoadhesive liposomal delivery system for risedronate: preparation and in vitro/in vivo characterization.

Authors:  Il-Woo Jung; Hyo-Kyung Han
Journal:  Int J Nanomedicine       Date:  2014-05-12

10.  Impact of multicellular tumor spheroids as an in vivo‑like tumor model on anticancer drug response.

Authors:  Bianca Galateanu; Ariana Hudita; Carolina Negrei; Rodica-Mariana Ion; Marieta Costache; Miriana Stan; Dragana Nikitovic; A Wallace Hayes; Demetrios A Spandidos; Aristidis M Tsatsakis; Octav Ginghina
Journal:  Int J Oncol       Date:  2016-04-01       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.